Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Supplements for Treating Autistic Spectrum Disorder

NCT06756711 is registered in ClinicalTrials.gov with Fundatia Bio-Forum as lead sponsor.

NCT NCT06756711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06756711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Supplements for Treating Autistic Spectrum Disorder
Lead sponsor
Fundatia Bio-Forum
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 10, 2024
Completion date
September 30, 2025
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder (asd